Summary of Purpose
The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thrombolysis has been achieved, and those whom it has not.Read More →
The following dates are available for this trial. Trial information last updated on 9 July 2015.
|1 Nov 2009||4 Jul 2015||1 May 2014||1 Dec 2014||1 Jul 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Prospective
- Sampling: Non-Probability Sample